Cutera, Inc. (NASDAQ:CUTR) develops, manufactures and markets a broad portfolio of laser and energy-based aesthetic systems for practitioners worldwide. Headquartered in Brisbane, California, the company’s product range addresses medical and cosmetic dermatology applications, including hair removal, skin revitalization, vascular lesion treatment and body sculpting. Since its founding in 1998, Cutera has focused on advancing non‐invasive technologies that deliver predictable clinical results and help practices differentiate their service offerings.
The Cutera product family encompasses a variety of platforms, each engineered to target specific treatment areas. Systems such as the Excel V™ utilize advanced laser wavelengths to treat vascular and pigmented lesions, while the truSculpt® line employs monopolar radiofrequency for body contouring and fat reduction. The company’s Secret RF™ technology delivers fractional radiofrequency energy to promote collagen remodeling and skin rejuvenation, and the Enlighten® series offers picosecond laser treatment for tattoo removal and pigmented lesions. Cutera also provides complementary accessories, software solutions and education programs to support clinical adoption and patient satisfaction.
With a global footprint spanning North America, Europe, the Asia‐Pacific region and select Latin American markets, Cutera sells its systems through a combination of direct sales teams and distribution partners. The company maintains manufacturing operations in the United States and collaborates with strategic suppliers to ensure product quality and scalability. In addition to ongoing device development, Cutera invests in clinical research and physician training to demonstrate safety, efficacy and optimal treatment protocols.
Under the leadership of President and Chief Executive Officer Christopher Capelli, Cutera’s management team brings decades of experience in medical devices, aesthetics and regulatory affairs. The company’s board and senior executives are committed to sustaining innovation by expanding the pipeline of energy‐based solutions and enhancing support services for aesthetic practices. As the demand for non‐invasive cosmetic treatments continues to grow, Cutera aims to leverage its technology expertise and global presence to capture opportunities across evolving markets.
AI Generated. May Contain Errors.
Free CUTR Stock Alerts